To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RND3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
442 supporting clones for gene RND3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC299174   .a 1 to 554 2 to 556   tiling clone,   556/556
(100 %)
2 diff
(99.7 %id)
DC299548   .a 1 to 572 2 to 574       574/574
(100 %)
2 diff
(99.7 %id)
DC424884   .a 61 to 607 1 to 547       547/547
(100 %)
0 diff
(100 %id)
AK313224   .a 61 to 1046 1 to 987 N199S     987/987
(100 %)
2 diff
(99.8 %id)
DC300001   .a 61 to 616 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
AL702949 human skeletal muscle .a 61 to 817 1 to 753       753/755
(99 %)
7 diff
(99.1 %id)
AL702945 human skeletal muscle .a 61 to 807 1 to 747       747/754
(99 %)
3 diff
(99.7 %id)
DC368138   .a 61 to 603 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
DC349124   .a 62 to 625 1 to 576       576/576
(100 %)
11 diff
(98.1 %id)
DC349389   .a 62 to 609 1 to 559       559/559
(100 %)
10 diff
(98.3 %id)
DA654214   .a 62 to 641 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DC364667   .a 62 to 625 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
DC384692   .a 62 to 603 1 to 554       554/554
(100 %)
4 diff
(99.3 %id)
DC425598   .a 62 to 624 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DA025467   .a 63 to 634 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA501626 brain .a 63 to 632 2 to 571   capped   570/571
(99 %)
2 diff
(99.7 %id)
DA660848   .a 63 to 641 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DC299781   .a 64 to 495 1 to 434       434/436
(99 %)
4 diff
(99.1 %id)
DW421223 Liver .a 64 to 343 18 to 298       281/298
(94 %)
6 diff
(98.0 %id)
DC367975   .a 64 to 611 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
DC368988   .a 64 to 603 1 to 541       541/541
(100 %)
2 diff
(99.7 %id)
DC413884 trachea .a 64 to 566 1 to 505       505/505
(100 %)
2 diff
(99.7 %id)
DA019825   .a 65 to 631 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA024456   .a 65 to 618 2 to 571   capped   570/570
(100 %)
11 diff
(98.1 %id)
DA029233   .a 65 to 504 2 to 456   capped   455/455
(100 %)
11 diff
(97.6 %id)
DA422022 cervix .a 65 to 649 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA478749   .a 65 to 613 2 to 563   capped   562/562
(100 %)
10 diff
(98.3 %id)
DA654311   .a 65 to 644 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA661700   .a 65 to 643 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA708323   .a 65 to 637 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
AL548164 placenta, Placenta Cot 25-normalized .a 68 to 871 1 to 800   fully sequenced,   800/800
(100 %)
25 diff
(96.9 %id)
TI_57179597   .a 68 to 792 32 to 759       728/760
(95 %)
9 diff
(98.9 %id)
DB014515 esophageal, tumor tissue .a 68 to 630 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
TI_57216540   .a 71 to 799 22 to 749       728/749
(97 %)
6 diff
(99.2 %id)
BI771861 pooled lung and spleen .a 72 to 792 1 to 724       724/725
(99 %)
5 diff
(99.4 %id)
BQ440721 melanotic melanoma, skin .a 72 to 872 12 to 815       804/815
(98 %)
6 diff
(99.3 %id)
DR760284 embryonic stem .a 72 to 869 1 to 796       796/796
(100 %)
2 diff
(99.8 %id)
AL120912 melanoma (MeWo cell line) .a 75 to 487 1 to 414       414/414
(100 %)
3 diff
(99.3 %id)
CA391345 eye, RPE/choroid .a 76 to 484 1 to 411       411/411
(100 %)
6 diff
(98.6 %id)
BI832695 pooled pancreas and spleen .a 76 to 738 1 to 660       633/718
(88 %)
56 diff
(92.3 %id)
BU166125 melanotic melanoma, skin .a 77 to 617 1 to 544       544/1065
(51 %)
8 diff
(99.3 %id)
BI755890 brain .a 78 to 799 1 to 721       721/721
(100 %)
2 diff
(99.8 %id)
CN481689 eye .a 79 to 662 24 to 620       597/620
(96 %)
6 diff
(99.1 %id)
AA852857 Bone, Hip .a 89 to 386 1 to 304       304/304
(100 %)
8 diff
(97.4 %id)
DN994835 brain, whole brain .a 89 to 793 8 to 715       708/715
(99 %)
6 diff
(99.2 %id)
X97758   .a 90 to 2826 1 to 2745 exact tiling clone,   2745/2745
(100 %)
16 diff
(99.5 %id)
AW451979   .a 91 to 267 206 to 31   AAA   176/189
(93 %)
10 diff
(94.8 %id)
AW452692   .a 91 to 267 206 to 31   AAA   176/189
(93 %)
12 diff
(93.7 %id)
BF510053   .a 91 to 267 206 to 31   AAA   176/189
(93 %)
10 diff
(94.8 %id)
BQ436975 melanotic melanoma, skin .a 104 to 982 1 to 879       879/879
(100 %)
10 diff
(98.9 %id)
U46459 liver cell line, pancreatic cancer .a 129 to 497 1 to 374       374/374
(100 %)
5 diff
(98.7 %id)
CN311453 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 136 to 399 1 to 265       265/265
(100 %)
3 diff
(98.9 %id)
DC299594   .a 138 to 723 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
TI_57164320   .a 196 to 1029 24 to 860       837/922
(90 %)
21 diff
(97.8 %id)
BI833996 pooled pancreas and spleen .a 197 to 1029 1 to 836       836/898
(93 %)
19 diff
(97.9 %id)
BQ605321 breast .a 239 to 745 507 to 1     Submitted on the opposite strand 507/507
(100 %)
10 diff
(98.1 %id)
AL572822 placenta, Placenta Cot 25-normalized .a 841 to 1817 976 to 1   fully sequenced,   976/976
(100 %)
15 diff
(98.5 %id)
BI060364 uterus_tumor .a 1220 to 1566 368 to 3       366/371
(98 %)
0 diff
(100 %id)
DN915118   .a 1364 to 1731 1 to 365       365/368
(99 %)
5 diff
(98.7 %id)
DA728262   .a 1375 to 2135 2 to 777   capped   776/804
(96 %)
12 diff
(98.6 %id)
BI051800 placenta_normal .a 1378 to 1589 214 to 2       213/219
(97 %)
0 diff
(100 %id)
TI_149280761   .a 1378 to 2022 725 to 78   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 648/813
(79 %)
11 diff
(98.7 %id)
CA311651 Human Lung Epithelial cells, lung .a 1378 to 1798 440 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 422/467
(90 %)
1 diff
(99.8 %id)
CN311456 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1383 to 1926 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
BE696013 colon .a 1386 to 1896 510 to 1   tiling clone,   510/510
(100 %)
5 diff
(99.1 %id)
BU198042 ectopic and normal uterine endometrium .a 1390 to 1649 1 to 260       260/261
(99 %)
3 diff
(98.9 %id)
CR597613 fetal brain .a 1393 to 2835 1 to 1443   tiling clone,   1443/1443
(100 %)
0 diff
(100 %id)
BX460517 brain, fetal brain .a 1393 to 2340 1 to 948       948/948
(100 %)
16 diff
(98.4 %id)
CN311459 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1433 to 1967 1 to 535       535/535
(100 %)
3 diff
(99.5 %id)
BM969930 lung, Primary Lung Epithelial Cells .a 1439 to 2022 603 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 585/585
(100 %)
3 diff
(99.5 %id)
H29347 whole brain .a 1450 to 1876 1 to 431       431/431
(100 %)
6 diff
(98.7 %id)
AA029235 uterus .a 1459 to 1722 1 to 264       264/273
(96 %)
1 diff
(99.7 %id)
R10814 liver and spleen .a 1492 to 1807 1 to 323       323/323
(100 %)
12 diff
(96.3 %id)
BF094408 uterus_tumor .a 1499 to 1860 1 to 360       360/360
(100 %)
9 diff
(97.5 %id)
BP289171 lung .a 1499 to 2077 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BG997966 head_neck .a 1500 to 1867 1 to 365       365/378
(96 %)
6 diff
(98.5 %id)
BP315236 mammary gland .a 1504 to 2087 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BQ355848 head_neck .a 1510 to 1860 9 to 356       348/356
(97 %)
8 diff
(97.8 %id)
BG989840 head_neck .a 1512 to 1787 309 to 38       272/309
(88 %)
0 diff
(100 %id)
CN311454 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1514 to 2248 1 to 735       735/735
(100 %)
0 diff
(100 %id)
T16826   .a 1533 to 1841 25 to 336       312/336
(92 %)
6 diff
(98.3 %id)
AA953196 Kidney, kidney tumor .a 1563 to 1850 289 to 1       289/289
(100 %)
1 diff
(99.7 %id)
CN485192 eye .a 1572 to 2208 1 to 637       637/637
(100 %)
0 diff
(100 %id)
H11949 whole brain .a 1573 to 2047 1 to 479     Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 479/481
(99 %)
11 diff
(97.8 %id)
AI537513 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1591 to 1807 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AA445965   .a 1593 to 2011 11 to 429     Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 419/429
(97 %)
6 diff
(98.7 %id)
AA443435   .a 1596 to 2162 1 to 567     Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 567/567
(100 %)
1 diff
(99.9 %id)
AW821812 stomach .a 1623 to 2198 24 to 598       575/598
(96 %)
10 diff
(98.4 %id)
BE937596 stomach .a 1623 to 2198 24 to 598       575/598
(96 %)
10 diff
(98.4 %id)
W24256 senescent fibroblast .a 1701 to 2136 1 to 438       438/438
(100 %)
4 diff
(99.1 %id)
W42968 senescent fibroblast .a 1724 to 2163 1 to 443       443/443
(100 %)
6 diff
(98.7 %id)
BM763305 myeloma .a 1731 to 2347 1 to 617       617/617
(100 %)
0 diff
(100 %id)
CN311457 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1741 to 1883 1 to 143       143/143
(100 %)
1 diff
(99.4 %id)
U46338 liver cell line, pancreatic cancer .a 1806 to 2042 1 to 240       240/240
(100 %)
11 diff
(95.5 %id)
BF693101 muscle (skeletal) .a 1846 to 2533 1 to 673       673/874
(77 %)
53 diff
(94.0 %id)
BP206345 coronary artery .a 1861 to 2440 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BP207288 coronary artery .a 1863 to 2445 1 to 582       582/582
(100 %)
17 diff
(97.1 %id)
BP367060 thymus .a 1882 to 2426 1 to 544       544/584
(93 %)
4 diff
(99.4 %id)
TI_149313932   .a 1884 to 2835 1020 to 87   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 934/988
(94 %)
27 diff
(97.3 %id)
AA010684 heart .a 1890 to 2205 1 to 317       317/317
(100 %)
3 diff
(99.1 %id)
CR739344 heart .a 1891 to 2263 1 to 379       379/379
(100 %)
9 diff
(97.7 %id)
TI_149284443   .a 1902 to 2361 525 to 69   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 457/1058
(43 %)
4 diff
(99.7 %id)
BM984470 lung, Primary Lung Epithelial Cells .a 1902 to 2361 473 to 17   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 457/462
(98 %)
4 diff
(99.2 %id)
CA310945 Human Lung Epithelial cells, lung .a 1902 to 2361 476 to 17   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 460/466
(98 %)
1 diff
(99.8 %id)
BG314741   .a 1913 to 2027 1 to 115       115/115
(100 %)
0 diff
(100 %id)
BE716834 head_neck .a 1915 to 2235 331 to 13       319/340
(93 %)
0 diff
(100 %id)
TI_149309787   .a 1916 to 2835 998 to 88   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 911/958
(95 %)
7 diff
(99.3 %id)
TI_149306146   .a 1917 to 2834 993 to 85   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 909/978
(92 %)
21 diff
(97.9 %id)
BX457996 neuroblastoma .a 1922 to 2815 893 to 1       893/893
(100 %)
11 diff
(98.8 %id)
BE789349 large cell carcinoma, lung .a 1929 to 2646 1 to 721       721/844
(85 %)
14 diff
(98.4 %id)
BX455105 brain, fetal brain .a 1947 to 2830 888 to 4       885/888
(99 %)
0 diff
(100 %id)
BM691483 eye, RPE and Choroid .a 1949 to 2471 8 to 530       523/530
(98 %)
6 diff
(98.9 %id)
FN067271 breast carcinoma .a 1974 to 2067 1 to 91       91/92
(98 %)
4 diff
(95.7 %id)
TI_154049627   .a 1978 to 2826 931 to 91   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 841/965
(87 %)
21 diff
(97.9 %id)
AV655899 corresponding non cancerous liver tissue .a 1987 to 2638 1 to 652     Submitted on the opposite strand 652/652
(100 %)
1 diff
(99.9 %id)
BE695893 colon .a 2016 to 2550 117 to 652       536/652
(82 %)
6 diff
(99.1 %id)
TI_149301859   .a 2021 to 2835 888 to 83   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 806/941
(85 %)
15 diff
(98.5 %id)
TI_149284109   .a 2028 to 2826 889 to 92   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 798/799
(99 %)
8 diff
(99.0 %id)
BM845572 lymph node, stomach .a 2048 to 2628 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BM845070 lymph node, stomach .a 2048 to 2670 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BQ007830 Chondrosarcoma, Left Pelvis .a 2057 to 2834 796 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 778/778
(100 %)
2 diff
(99.8 %id)
CA314793 Human Lung Epithelial cells, lung .a 2060 to 2826 786 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 768/768
(100 %)
6 diff
(99.3 %id)
CA422962 cell lines, Chondrosarcoma .a 2060 to 2835 793 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 775/775
(100 %)
3 diff
(99.7 %id)
CA423225 cell lines, Chondrosarcoma .a 2060 to 2826 785 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 767/767
(100 %)
3 diff
(99.7 %id)
W16987 lung .a 2070 to 2328 1 to 260       260/260
(100 %)
2 diff
(99.3 %id)
BU616881 Cell Line, Chondrosarcoma .a 2109 to 2835 746 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 728/728
(100 %)
2 diff
(99.8 %id)
AA037435 uterus .a 2113 to 2484 1 to 380   fully sequenced,   380/380
(100 %)
12 diff
(96.9 %id)
W30971 senescent fibroblast .a 2114 to 2660 1 to 551       551/554
(99 %)
16 diff
(97.2 %id)
CA443828 Fibrosarcoma .a 2116 to 2823 730 to 22   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 709/712
(99 %)
0 diff
(100 %id)
BU943776 mixed (pool of 40 RNAs) .a 2119 to 2824 1 to 706       706/707
(99 %)
7 diff
(99.1 %id)
CA314803 Human Lung Epithelial cells, lung .a 2124 to 2826 722 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 704/704
(100 %)
2 diff
(99.8 %id)
BU629569 cell lines, Chondrosarcoma .a 2127 to 2835 727 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 709/709
(100 %)
2 diff
(99.8 %id)
BU686220 lung, Primary Lung Epithelial Cells .a 2137 to 2834 713 to 16   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 698/698
(100 %)
1 diff
(99.9 %id)
BU628110 Bone, Enchondroma cell line .a 2141 to 2826 705 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 687/687
(100 %)
2 diff
(99.8 %id)
CA421487 Chondrosarcoma Grade II, Left Pelvis .a 2143 to 2826 698 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 680/680
(100 %)
8 diff
(98.9 %id)
BU688155 lung .a 2144 to 2835 711 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 693/693
(100 %)
1 diff
(99.9 %id)
BM980147 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2144 to 2835 711 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 693/693
(100 %)
2 diff
(99.8 %id)
CA314525 Human Lung Epithelial cells, lung .a 2147 to 2833 704 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 686/698
(98 %)
3 diff
(99.6 %id)
TI_151714710   .a 2156 to 2826 819 to 139       681/1068
(63 %)
0 diff
(100 %id)
BQ019859 Chondrosarcoma, Left Pubic Bone .a 2162 to 2827 685 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 667/667
(100 %)
5 diff
(99.3 %id)
CB305755 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2162 to 2835 693 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 675/675
(100 %)
2 diff
(99.8 %id)
N75094 multiple sclerosis lesions .a 2166 to 2415 1 to 252   fully sequenced,   252/252
(100 %)
2 diff
(99.3 %id)
TI_57230822   .a 2169 to 2827 54 to 710       657/746
(88 %)
7 diff
(99.1 %id)
BI871681 adenocarcinoma, cell line, Liver .a 2170 to 2827 1 to 656       656/670
(97 %)
7 diff
(99.0 %id)
AA040883 uterus .a 2177 to 2422 1 to 247       247/248
(99 %)
8 diff
(96.8 %id)
BX409754 brain, fetal brain .a 2178 to 2835 1 to 656       656/656
(100 %)
5 diff
(99.3 %id)
BU680315 lung, Primary Lung Epithelial Cells .a 2181 to 2826 665 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 647/647
(100 %)
3 diff
(99.6 %id)
ES310442 scalp interfollicular dermis, skin .a 2182 to 2827 684 to 41     Submitted on the opposite strand 644/687
(93 %)
0 diff
(100 %id)
BU736064 eye, fetal eyes .a 2224 to 2826 622 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
CA413631 Chondrosarcoma Grade II, Left Pelvis .a 2239 to 2826 608 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 590/590
(100 %)
2 diff
(99.7 %id)
BQ067773 brain .a 2245 to 2827 15 to 597       583/658
(88 %)
2 diff
(99.7 %id)
BG314761   .a 2253 to 2368 116 to 1       116/117
(99 %)
0 diff
(100 %id)
BG054844 brain, glioblastoma (pooled) .a 2256 to 2826 572 to 1       572/572
(100 %)
1 diff
(99.9 %id)
BQ018209 lung, Metastatic Chondrosarcoma .a 2261 to 2823 585 to 22   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 564/567
(99 %)
0 diff
(100 %id)
DN915119   .a 2284 to 2834 553 to 2       552/553
(99 %)
0 diff
(100 %id)
DN919791   .a 2289 to 2824 539 to 3       537/539
(99 %)
0 diff
(100 %id)
CD216783 lung .a 2291 to 2834 1 to 545   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 545/546
(99 %)
2 diff
(99.7 %id)
TI_151737563   .a 2297 to 2826 642 to 111       532/642
(82 %)
0 diff
(100 %id)
BF438340 Prostate .a 2300 to 2696 398 to 1       398/398
(100 %)
1 diff
(99.8 %id)
AA587167 larynx .a 2307 to 2676 370 to 1       370/370
(100 %)
0 diff
(100 %id)
W69514 heart .a 2308 to 2613 1 to 308   fully sequenced, Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 308/308
(100 %)
1 diff
(99.7 %id)
AI963174 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2316 to 2827 515 to 2       514/515
(99 %)
0 diff
(100 %id)
AW151025 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2316 to 2826 515 to 4       512/515
(99 %)
0 diff
(100 %id)
AA082152 heart .a 2317 to 2629 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
AA528703 alveolar rhabdomyosarcoma .a 2322 to 2838 523 to 6       518/523
(99 %)
0 diff
(100 %id)
AI624405 adenocarcinoma, Pancreas .a 2323 to 2835 514 to 1       514/514
(100 %)
2 diff
(99.7 %id)
AI653778 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2323 to 2826 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
FN169496 breast carcinoma .a 2325 to 2435 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
CB243500 Human Lung Epithelial cells, lung .a 2325 to 2823 521 to 22   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 500/512
(97 %)
0 diff
(100 %id)
TI_154191631   .a 2334 to 2835 49 to 551   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 503/503
(100 %)
1 diff
(99.9 %id)
CF127383 Chondrosarcoma Lung Metastasis cell lines, lung .a 2336 to 2835 1 to 501   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 501/501
(100 %)
1 diff
(99.9 %id)
AW474477 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2337 to 2826 491 to 1       491/491
(100 %)
1 diff
(99.8 %id)
AI453116 pooled .a 2350 to 2838 495 to 6       490/495
(98 %)
0 diff
(100 %id)
AI377033   .a 2355 to 2838 489 to 5       485/489
(99 %)
0 diff
(100 %id)
AA010685 heart .a 2359 to 2834 482 to 1       482/483
(99 %)
8 diff
(98.4 %id)
AI818033 normal prostate, Prostate .a 2360 to 2826 468 to 1       468/468
(100 %)
4 diff
(99.2 %id)
AA594796 breast .a 2367 to 2826 466 to 5       462/466
(99 %)
0 diff
(100 %id)
AI569594 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2371 to 2826 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
C21363   .a 2373 to 2717 1 to 345       345/348
(99 %)
1 diff
(99.8 %id)
H17505 whole brain .a 2380 to 2826 464 to 9       456/468
(97 %)
0 diff
(100 %id)
AI041658 senescent fibroblast .a 2382 to 2816 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
N52324 multiple sclerosis lesions .a 2385 to 2836 458 to 1   fully sequenced,   458/458
(100 %)
4 diff
(99.2 %id)
AW069228 bone marrow stroma .a 2403 to 2834 451 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 433/433
(100 %)
1 diff
(99.8 %id)
H29264 whole brain .a 2404 to 2838 448 to 6       443/450
(98 %)
0 diff
(100 %id)
CA444026 Fibrosarcoma .a 2405 to 2823 441 to 22   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 420/423
(99 %)
0 diff
(100 %id)
CA443767 lung, Metastatic Chondrosarcoma .a 2406 to 2835 448 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 430/430
(100 %)
3 diff
(99.4 %id)
AA029236 uterus .a 2407 to 2835 435 to 1       435/435
(100 %)
6 diff
(98.7 %id)
N71756 melanocyte .a 2411 to 2826 429 to 1       429/431
(99 %)
11 diff
(97.5 %id)
BF939705 brain, glioblastoma (pooled) .a 2412 to 2823 416 to 5       412/416
(99 %)
0 diff
(100 %id)
AI129127 senescent fibroblast .a 2414 to 2826 428 to 15   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 414/414
(100 %)
1 diff
(99.8 %id)
AI587174 adenocarcinoma, Pancreas .a 2414 to 2827 432 to 16   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 417/417
(100 %)
6 diff
(98.6 %id)
AI624070 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2416 to 2826 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AA430018   .a 2427 to 2835 424 to 15   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
C75191   .a 2433 to 2801 369 to 1       369/369
(100 %)
0 diff
(100 %id)
BP425026 small intestine .a 2436 to 2827 1 to 395     Submitted on the opposite strand 395/395
(100 %)
3 diff
(99.3 %id)
AI752975 bone marrow stroma .a 2438 to 2835 417 to 18   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 400/400
(100 %)
2 diff
(99.5 %id)
AI446683 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2444 to 2837 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
T16825   .a 2444 to 2826 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
CN311460 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2447 to 2827 10 to 391   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 382/391
(97 %)
6 diff
(98.5 %id)
CD676726 eye, Trabecular meshwork .a 2452 to 2808 1 to 357   AAA   357/372
(95 %)
6 diff
(98.4 %id)
AI143000 senescent fibroblast .a 2452 to 2826 385 to 10       376/385
(97 %)
0 diff
(100 %id)
CB048790 Prostate .a 2453 to 2833 10 to 390   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 381/390
(97 %)
6 diff
(98.5 %id)
AA037493 uterus .a 2454 to 2827 379 to 1   fully sequenced,   379/379
(100 %)
2 diff
(99.5 %id)
AI613239 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2454 to 2826 375 to 2       374/375
(99 %)
0 diff
(100 %id)
AW073733 2 pooled high-grade transitional celltumors, genitourinary tract .a 2455 to 2826 373 to 1       373/373
(100 %)
2 diff
(99.5 %id)
AA948343 2 pooled tumors (clear cell type), Kidney .a 2456 to 2838 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
CN311458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2458 to 2826 1 to 370   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 370/370
(100 %)
1 diff
(99.8 %id)
AA969758 2 pooled tumors (clear cell type), Kidney .a 2458 to 2835 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AI750200 Bone, Hip .a 2458 to 2805 344 to 10       335/344
(97 %)
0 diff
(100 %id)
AA443302   .a 2481 to 2835 370 to 15   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 356/356
(100 %)
1 diff
(99.8 %id)
AA908310 ovary, serous adenocarcinoma .a 2483 to 2826 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AA918635 Kidney .a 2491 to 2826 338 to 2       337/338
(99 %)
0 diff
(100 %id)
AA865225 2 pooled tumors (clear cell type), Kidney .a 2492 to 2838 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
AA852858 Bone, Hip .a 2496 to 2788 300 to 8       293/300
(97 %)
0 diff
(100 %id)
BP388593 pancreatic islet .a 2498 to 2787 1 to 292     Submitted on the opposite strand 292/292
(100 %)
2 diff
(99.4 %id)
AI247214 Kidney .a 2510 to 2838 327 to 1       327/352
(92 %)
8 diff
(97.8 %id)
AI303019 2 pooled tumors (clear cell type), Kidney .a 2510 to 2826 321 to 4       318/321
(99 %)
0 diff
(100 %id)
R10718 liver and spleen .a 2515 to 2824 318 to 1       318/348
(91 %)
11 diff
(96.9 %id)
AI953533 normal epithelium, ovary .a 2541 to 2835 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
T30006 adipose .a 2546 to 2803 262 to 5       258/262
(98 %)
0 diff
(100 %id)
N98483 senescent fibroblast .a 2578 to 2826 256 to 7       250/256
(97 %)
0 diff
(100 %id)
W42969 senescent fibroblast .a 2583 to 2811 230 to 1       230/230
(100 %)
1 diff
(99.6 %id)
W69431 heart .a 2583 to 2826 268 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 246/246
(100 %)
1 diff
(99.6 %id)
AW798430 uterus .a 2584 to 2845 7 to 268   tiling clone,   262/269
(97 %)
5 diff
(98.2 %id)
H11950 whole brain .a 2592 to 2826 261 to 25   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 237/237
(100 %)
6 diff
(97.5 %id)
AA877385 2 pooled tumors (clear cell type), Kidney .a 2611 to 2838 233 to 5       229/233
(98 %)
0 diff
(100 %id)
N66700 multiple sclerosis lesions .a 2664 to 2838 177 to 2       176/182
(96 %)
0 diff
(100 %id)
AI288055 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2695 to 2835 142 to 1       142/142
(100 %)
1 diff
(99.3 %id)
DA475785   .b 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BP230174 brain .b 32 to 613 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DC367501   .b 33 to 531 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BP231639 muscle .b 34 to 614 1 to 583       583/583
(100 %)
8 diff
(98.7 %id)
CB960665 Human Placenta, placenta .b 56 to 755 22 to 729       708/764
(92 %)
20 diff
(97.4 %id)
CF594049 Human Placenta, placenta .b 56 to 795 23 to 762       740/845
(87 %)
9 diff
(99.0 %id)
DC373873 tongue .b 59 to 629 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC375215 brain .b 59 to 630 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
DN919792   .b 61 to 176 1 to 116       116/116
(100 %)
2 diff
(98.3 %id)
DC375629 brain .b 61 to 630 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC384807   .b 61 to 629 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DW461485 Liver .b 62 to 170 18 to 126       109/127
(85 %)
1 diff
(99.3 %id)
DC357556   .b 62 to 647 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DC425154   .b 62 to 625 1 to 564       564/564
(100 %)
0 diff
(100 %id)
AU280574   .b 62 to 632 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC421344 uterus .b 62 to 623 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DC350115 brain .b 63 to 517 1 to 455       455/455
(100 %)
0 diff
(100 %id)
NM_005168.3   .b 63 to 2745 1 to 2683 exact RefSeq,   2683/2683
(100 %)
0 diff
(100 %id)
BP354466   .b 63 to 644 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DC299129   .b 64 to 630 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DC299221   .b 64 to 626 1 to 563       563/563
(100 %)
0 diff
(100 %id)
DC299260   .b 64 to 642 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
DC299471   .b 64 to 631 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC300002   .b 64 to 639 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DC300044   .b 64 to 635 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC300836 bladder .b 64 to 625 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC424969   .b 64 to 633 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC346431 tongue, tumor tissue .b 64 to 650 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DC348592   .b 64 to 624 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC349130   .b 64 to 628 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BP229813 brain .b 64 to 645 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC353118 brain .b 64 to 623 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC354082 brain .b 64 to 641 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DC355046   .b 64 to 634 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC355161   .b 64 to 632 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
DC356378   .b 64 to 622 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BP237162 coronary artery .b 64 to 646 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DC357961   .b 64 to 624 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC358081   .b 64 to 635 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DC358460 lung .b 64 to 409 1 to 346       346/346
(100 %)
0 diff
(100 %id)
DC358784 lung .b 64 to 659 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BP279429   .b 64 to 645 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
DC363491   .b 64 to 634 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
DC364296   .b 64 to 629 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC428479   .b 64 to 609 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
DC368746   .b 64 to 619 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
DC368845   .b 64 to 524 1 to 461       461/461
(100 %)
3 diff
(99.4 %id)
DC375805 brain .b 64 to 241 1 to 178       178/178
(100 %)
0 diff
(100 %id)
DC379830 pericardium .b 64 to 624 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC384555   .b 64 to 638 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BP339154 Spleen .b 64 to 633 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BP345044 synovial membrane .b 64 to 644 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DC425667   .b 64 to 618 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC409204 thymus .b 64 to 621 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
DC414084 trachea .b 64 to 642 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC414168 trachea .b 64 to 529 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
DC420314 uterus .b 64 to 521 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
DA021968   .b 65 to 539 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DA649510   .b 65 to 597 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA651532   .b 65 to 599 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA662767   .b 65 to 592 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA766894 tongue .b 65 to 579 2 to 516   capped   515/515
(100 %)
1 diff
(99.9 %id)
DA787710 brain .b 65 to 566 2 to 503   capped   502/510
(98 %)
0 diff
(100 %id)
DC365839   .b 66 to 619 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC371198   .b 66 to 632 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BP258412 heart .b 67 to 632 1 to 565       565/565
(100 %)
22 diff
(96.2 %id)
DC355265   .b 68 to 641 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
DC363211   .b 68 to 610 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DB194779 trachea .b 68 to 596 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BG117409 adenocarcinoma, cell line, Liver .b 72 to 773 1 to 703       703/1098
(64 %)
11 diff
(99.0 %id)
BC012513 Kidney, hypernephroma .b 79 to 2742 1 to 2667 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 2667/2667
(100 %)
3 diff
(99.9 %id)
BG118494 adenocarcinoma, cell line, Liver .b 80 to 853 1 to 774       774/853
(90 %)
8 diff
(99.1 %id)
BG165500 hypernephroma, cell line, Kidney .b 80 to 702 1 to 648       582/696
(83 %)
38 diff
(94.6 %id)
AA115811 colon, tumor .b 86 to 492 1 to 414     Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 414/414
(100 %)
8 diff
(98.1 %id)
CN484360 eye .b 89 to 699 1 to 611       611/611
(100 %)
0 diff
(100 %id)
TI_57242490   .b 89 to 745 69 to 725       657/726
(90 %)
9 diff
(98.8 %id)
N44809 melanocyte .b 92 to 316 1 to 225       225/230
(97 %)
2 diff
(99.2 %id)
BI917896 brain .b 93 to 745 1 to 653       653/654
(99 %)
3 diff
(99.6 %id)
BY795113 eye .b 97 to 686 1 to 590       590/590
(100 %)
0 diff
(100 %id)
DB015304 esophageal, tumor tissue .b 103 to 566 2 to 464   capped   463/471
(98 %)
4 diff
(99.2 %id)
BP365551 lung .b 111 to 689 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
DA034012   .b 117 to 689 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
T58202 fetal spleen, Spleen .b 125 to 450 1 to 331       331/331
(100 %)
7 diff
(97.9 %id)
W86282 liver and spleen .b 172 to 654 1 to 491     Submitted on the opposite strand 491/491
(100 %)
9 diff
(98.2 %id)
BF509678   .b 172 to 668 15 to 511     Submitted on the opposite strand 497/497
(100 %)
4 diff
(99.2 %id)
AA777317 liver and spleen .b 178 to 665 1 to 488     Submitted on the opposite strand 488/488
(100 %)
1 diff
(99.8 %id)
W88811 liver and spleen .b 189 to 594 1 to 412     Submitted on the opposite strand 412/413
(99 %)
8 diff
(98.1 %id)
CB565891 mixed .b 217 to 953 1 to 737 exact     737/738
(99 %)
2 diff
(99.8 %id)
AF498969 placenta .b 219 to 953 1 to 735 exact     735/735
(100 %)
0 diff
(100 %id)
BT006769   .b 219 to 951 1 to 733       733/735
(99 %)
1 diff
(99.9 %id)
CV023988 mixed .b 219 to 899 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
TI_1948101010   .b 219 to 649 121 to 551   fully sequenced, AAA   431/551
(78 %)
6 diff
(99.0 %id)
TI_1948101157   .b 219 to 559 129 to 469       341/368
(92 %)
6 diff
(98.4 %id)
TI_1948101304   .b 219 to 566 129 to 476       348/384
(90 %)
6 diff
(98.5 %id)
TI_1948101437   .b 219 to 527 123 to 431   fully sequenced,   309/431
(71 %)
6 diff
(98.7 %id)
X95282 Spleen .b 219 to 953 1 to 735 exact     735/735
(100 %)
0 diff
(100 %id)
S82240   .b 240 to 1073 1 to 833       833/833
(100 %)
1 diff
(99.9 %id)
BF928578 nervous_tumor .b 254 to 495 249 to 10     Submitted on the opposite strand 240/249
(96 %)
1 diff
(99.6 %id)
CR542038   .b 264 to 953 1 to 690       690/690
(100 %)
1 diff
(99.9 %id)
CR542070   .b 264 to 950 1 to 687       687/687
(100 %)
0 diff
(100 %id)
BQ720259 sympathetic trunk .b 265 to 1137 1 to 874       874/875
(99 %)
12 diff
(98.7 %id)
BG314793   .b 272 to 406 1 to 136       136/136
(100 %)
3 diff
(97.8 %id)
BF171044 blood .b 295 to 603 1 to 305       305/306
(99 %)
9 diff
(97.1 %id)
DA438929 tongue, tumor tissue .b 300 to 883 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB174732 kidney, tumor tissue .b 330 to 895 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA576349   .b 410 to 969 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP266706 thyroid .b 414 to 994 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DR762097 embryonic stem .b 419 to 1237 1 to 819       819/819
(100 %)
5 diff
(99.4 %id)
W88810 liver and spleen .b 436 to 865 430 to 1     Submitted on the opposite strand 430/431
(99 %)
6 diff
(98.7 %id)
BP291050 lung .b 436 to 1018 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA475660   .b 452 to 1006 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AI750201 Bone, Hip .b 461 to 873 1 to 412       412/412
(100 %)
6 diff
(98.6 %id)
W86326 liver and spleen .b 462 to 890 435 to 1     Submitted on the opposite strand 435/438
(99 %)
8 diff
(98.2 %id)
H96700 melanocyte .b 470 to 608 1 to 139       139/145
(95 %)
2 diff
(98.7 %id)
DB199467 trachea .b 470 to 1043 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BQ880029 dorsal root ganglia .b 478 to 1325 19 to 872       854/880
(97 %)
25 diff
(97.2 %id)
CN311452 embryonic stem cells, cell lines H1, H7, andH9 .b 485 to 1000 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
TI_1948101438   .b 497 to 952 578 to 123   fully sequenced,   456/578
(78 %)
0 diff
(100 %id)
DA577079   .b 499 to 1059 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BF733742 amnion_normal .b 512 to 858 357 to 11     Submitted on the opposite strand 347/357
(97 %)
1 diff
(99.8 %id)
DA997934   .b 519 to 1066 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BQ303210 breast .b 520 to 903 425 to 41       385/425
(90 %)
0 diff
(100 %id)
DA600104   .b 521 to 1066 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CU442895 epidermis .b 527 to 1144 625 to 8     Submitted on the opposite strand 618/627
(98 %)
4 diff
(99.4 %id)
CU444242 epidermis .b 527 to 1144 625 to 8     Submitted on the opposite strand 618/627
(98 %)
4 diff
(99.4 %id)
BE170512 head_neck .b 537 to 684 13 to 161       149/165
(90 %)
8 diff
(95.2 %id)
BG260108 bladder, transitional cell papilloma, cell line .b 574 to 1171 1 to 604       604/1236
(48 %)
11 diff
(99.2 %id)
DA748774   .b 604 to 1162 2 to 559   capped   558/565
(98 %)
1 diff
(99.9 %id)
AU120255 whole embryo, mainly body .b 608 to 1299 2 to 693   capped   692/700
(98 %)
9 diff
(98.8 %id)
TI_1948101011   .b 619 to 952 460 to 127   fully sequenced,   334/460
(72 %)
0 diff
(100 %id)
AW580862 leiomios .b 620 to 1081 1 to 467       467/467
(100 %)
24 diff
(94.9 %id)
CB266344 adipose .b 620 to 1185 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BQ879015 dorsal root ganglia .b 623 to 1516 1 to 897       897/897
(100 %)
3 diff
(99.7 %id)
BP291720 lung .b 625 to 1205 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
TI_1948101158   .b 629 to 952 448 to 125       324/351
(92 %)
0 diff
(100 %id)
BX431772 fetal liver, Liver .b 644 to 1542 1 to 906       906/906
(100 %)
20 diff
(97.8 %id)
TI_1948101305   .b 650 to 952 422 to 120       303/330
(91 %)
0 diff
(100 %id)
DA485087 brain .b 653 to 1231 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CN311450 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 673 to 1275 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
AW385723 leiomios .b 699 to 1170 21 to 489       469/498
(94 %)
10 diff
(98.0 %id)
BX345598 Placenta Cot 25-normalized .b 702 to 1670 974 to 1       974/974
(100 %)
59 diff
(94.0 %id)
AV647608 corresponding non cancerous liver tissue .b 722 to 1359 1 to 633     Submitted on the opposite strand 633/633
(100 %)
22 diff
(96.6 %id)
CU452984 epidermis .b 735 to 1144 417 to 8     Submitted on the opposite strand 410/417
(98 %)
0 diff
(100 %id)
BQ695270 adipose .b 737 to 1198 1 to 462       462/462
(100 %)
2 diff
(99.6 %id)
DA576484   .b 739 to 1287 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA931083 small intestine .b 744 to 1317 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
CU451841 epidermis .b 756 to 1144 396 to 8     Submitted on the opposite strand 389/396
(98 %)
0 diff
(100 %id)
CA390876 eye, RPE/choroid .b 762 to 1382 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
AU310273 neuroblastoma .b 765 to 1334 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
DA549491   .b 767 to 1332 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
F12790 brain, total brain .b 770 to 1068 1 to 299       299/299
(100 %)
0 diff
(100 %id)
BQ009500 Chondrosarcoma, Left Pubic Bone .b 775 to 1330 576 to 20   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 557/557
(100 %)
22 diff
(96.1 %id)
CD677063 eye, Trabecular meshwork .b 778 to 1380 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
BP337531 coronary artery .b 792 to 1377 1 to 585       585/587
(99 %)
19 diff
(96.8 %id)
T75089 whole brain .b 812 to 1078 1 to 267       267/267
(100 %)
4 diff
(98.6 %id)
CN311451 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 821 to 1489 1 to 672       672/672
(100 %)
3 diff
(99.6 %id)
CN311455 embryonic stem cells, DMSO-treated H9 cellline .b 824 to 1487 9 to 673       665/673
(98 %)
6 diff
(99.2 %id)
BE813011 amnion_normal .b 829 to 1365 1 to 538       538/543
(99 %)
6 diff
(98.9 %id)
BX495381 Liver .b 834 to 1337 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
DA370960 thalamus .b 844 to 1393 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
FN046555 breast carcinoma .b 845 to 898 1 to 55       55/55
(100 %)
1 diff
(98.2 %id)
BP342739 stomach mucosa .b 847 to 1344 1 to 500       500/518
(96 %)
6 diff
(98.9 %id)
BP417547 small intestine .b 854 to 1211 1 to 358     Submitted on the opposite strand 358/358
(100 %)
1 diff
(99.8 %id)
AA093817   .b 863 to 1027 1 to 159       159/163
(97 %)
11 diff
(93.3 %id)
BQ307485 breast .b 867 to 1212 1 to 347       347/347
(100 %)
7 diff
(98.0 %id)
FN103019 breast carcinoma .b 874 to 954 80 to 1     Submitted on the opposite strand 80/81
(98 %)
1 diff
(98.8 %id)
DA569957 whole embryo, mainly head .b 911 to 1650 2 to 750   capped   749/775
(96 %)
17 diff
(97.9 %id)
BG290293 bladder, transitional cell papilloma, cell line .b 929 to 1623 1 to 723       723/723
(100 %)
67 diff
(90.8 %id)
CN311449 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 935 to 1352 8 to 428       421/428
(98 %)
6 diff
(98.6 %id)
AV652953 corresponding non cancerous liver tissue .b 935 to 1359 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
BI059524 uterus_tumor .b 958 to 1397 443 to 1       443/443
(100 %)
11 diff
(97.6 %id)
CD709529 normal nasopharynx .b 978 to 1458 33 to 515       483/515
(93 %)
6 diff
(98.9 %id)
BQ000191 Fibrosarcoma .b 993 to 1708 736 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 718/718
(100 %)
2 diff
(99.8 %id)
CA427453 Cell Line, Chondrosarcoma .b 993 to 1714 743 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 725/725
(100 %)
2 diff
(99.8 %id)
BU622014 Cell Line, Chondrosarcoma .b 1006 to 1714 730 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 712/712
(100 %)
2 diff
(99.8 %id)
BP261885 small intestine .b 1030 to 1608 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CA310320 Alveolar Macrophage, lung .b 1037 to 1779 765 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 747/747
(100 %)
2 diff
(99.8 %id)
AA248057   .b 1040 to 1180 1 to 138       138/142
(97 %)
6 diff
(95.8 %id)
TI_154100168   .b 1055 to 1714 758 to 97   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 662/663
(99 %)
1 diff
(99.9 %id)
CA441213 Fibrosarcoma .b 1078 to 1714 657 to 19   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 639/639
(100 %)
1 diff
(99.9 %id)
BP261487 small intestine .b 1136 to 1712 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
BP290231 lung .b 1143 to 1606 1 to 464       464/569
(81 %)
30 diff
(94.8 %id)
DA568151 whole embryo, mainly head .b 1153 to 1884 2 to 739   tiling clone, capped   738/749
(98 %)
7 diff
(99.1 %id)
BM759532 Ascites, stomach .b 1157 to 1681 1 to 526       526/526
(100 %)
7 diff
(98.7 %id)
BP268595 thyroid .b 1199 to 1768 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
BP269154 thyroid .b 1199 to 1779 1 to 584       584/584
(100 %)
7 diff
(98.9 %id)
H96577 melanocyte .b 1201 to 1632 441 to 1       441/442
(99 %)
8 diff
(98.2 %id)
AW518693 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1262 to 1716 456 to 3       454/456
(99 %)
0 diff
(100 %id)
DB354628 whole embryo, mainly head .b 2175 to 2742 565 to 1   tiling clone,   565/567
(99 %)
17 diff
(97.1 %id)
DB358915 whole embryo, mainly body .b 2175 to 2733 559 to 1       559/560
(99 %)
24 diff
(95.8 %id)
DB356676 whole embryo, mainly head .b 2185 to 2742 559 to 1       559/563
(99 %)
16 diff
(97.2 %id)
AA115812 colon, tumor .b 2305 to 2742 456 to 11   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 446/448
(99 %)
10 diff
(97.8 %id)
N35505 melanocyte .b 2308 to 2733 431 to 1       431/431
(100 %)
5 diff
(98.9 %id)
R38527 whole brain .b 2380 to 2724 360 to 3       358/363
(98 %)
0 diff
(100 %id)
CR607069 Placenta Cot 25-normalized .c 1 to 1747 1 to 1747 exact tiling clone,   1747/1747
(100 %)
0 diff
(100 %id)
CR626467 Placenta Cot 25-normalized .c 6 to 1693 1 to 1688 exact     1688/1688
(100 %)
0 diff
(100 %id)
BQ434193 melanotic melanoma, skin .d 1 to 879 1 to 882 exact tiling clone,   882/884
(99 %)
15 diff
(98.4 %id)
DC352008 brain .e 1 to 568 4 to 571 exact tiling clone,   571/571
(100 %)
1 diff
(99.9 %id)
DC347036 tongue, tumor tissue .f 1 to 545 24 to 570 exact tiling clone,   547/570
(95 %)
6 diff
(99.0 %id)
DA777233 brain .g 1 to 504 2 to 505 L73S S112R tiling clone, capped   504/509
(99 %)
3 diff
(99.5 %id)
DC376415 brain .h 1 to 452 1 to 454 M75N L76A V78G G79R C80L ... tiling clone,   454/461
(98 %)
3 diff
(99.4 %id)
BE178611 head_neck .i 1 to 445 448 to 3   tiling clone, Submitted on the opposite strand 446/450
(99 %)
0 diff
(100 %id)
BE004578 breast_normal .i 4 to 450 4 to 448   tiling clone,   445/448
(99 %)
6 diff
(98.7 %id)
AW804054 uterus .i 27 to 448 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AW804058 uterus .i 50 to 387 330 to 1   tiling clone,   330/393
(83 %)
10 diff
(97.5 %id)
CV346696 breast_normal .i 62 to 240 46 to 228       183/228
(80 %)
6 diff
(97.4 %id)
AL602713 human skeletal muscle .i 231 to 846 1 to 615   tiling clone,   615/615
(100 %)
1 diff
(99.9 %id)
CV346716 breast_normal .i 357 to 459 109 to 5     Submitted on the opposite strand 105/125
(84 %)
0 diff
(100 %id)
BF841192 head_neck .i 579 to 1010 447 to 16 N35I M36W A37P K38N Q39R ... tiling clone, Submitted on the opposite strand 432/447
(96 %)
19 diff
(95.8 %id)
AK309442 brain .j 1 to 888 2 to 889 exact tiling clone,   889/889
(100 %)
0 diff
(100 %id)
DA532407 brain .j 1 to 578 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA854831 placenta .k-u 1 to 586 2 to 585 L5F S48F F49H I50S V51G ... tiling clone, capped   584/584
(100 %)
2 diff
(99.7 %id)
DW431427 Liver .l-u 1 to 225 18 to 243 exact AAA   226/243
(93 %)
6 diff
(97.6 %id)
DW441250 Liver .l-u 1 to 365 18 to 379 exact tiling clone,   362/379
(95 %)
6 diff
(98.5 %id)
DW441251 Liver .l-u 1 to 361 18 to 379 exact tiling clone,   362/379
(95 %)
10 diff
(97.4 %id)
AA603081 normal prostate, Prostate .l-u 212 to 490 310 to 34   tiling clone, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 277/277
(100 %)
10 diff
(96.4 %id)
DW433898 Liver .l-u 250 to 493 17 to 260   tiling clone,   244/260
(93 %)
6 diff
(97.7 %id)
AA329173   .m 1 to 226 1 to 225 S32P K33R N34I tiling clone,   225/264
(85 %)
4 diff
(98.5 %id)
R18107 liver and spleen .m 109 to 459 12 to 366       358/366
(97 %)
11 diff
(97.0 %id)
R10249 liver and spleen .m 109 to 474 14 to 385   tiling clone,   372/404
(92 %)
13 diff
(96.8 %id)
H69633 liver and spleen .m 111 to 461 1 to 353   tiling clone,   353/353
(100 %)
2 diff
(99.5 %id)
BE185205 head_neck .n-u 1 to 214 1 to 214 exact tiling clone,   214/223
(95 %)
3 diff
(98.7 %id)
AK298007 lung Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
AK299731 brain Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
AK311312 brain Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
DC349662 brain Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
AV646935 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand    
AV646936 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand    
AV647514 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand    
AV647555 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV647774 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand    
AV653593 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV654752 corresponding non cancerous liver tissue Gene RND3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BJ990266 hepatoblastoma Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
BJ990267 hepatoblastoma Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
DC358322 lung Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
N67837 melanocyte Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
W03441 melanocyte Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
CD643122 Embryonic Stem cells Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
CD651943 Embryonic Stem cells Gene RND3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI